Maxime Verhoeven

249 List of conference abstracts U-Act-Early trial 3 years follow-up. The longer effectiveness of treat-to-target strategies in early rheumatoid arthritis with tocilizumab, methotrexate, or their combination. Oral presentation at the NVR congress 2018, September 27-28, Arnhem, the Netherlands. An indirect comparison of effectiveness and safety of three treat-to-target treatment strategies: Tocilizumab with or without MTX and MTX with prednisone. Poster presentation at the NVR congress 2018, September 27-28, Arnhem, the Netherlands. U-Act-Early trial 3 years follow-up. The longer effectiveness of treat-to-target strategies in early rheumatoid arthritis with tocilizumab, methotrexate, or their combination. Poster presentation at the EULAR congress 2018, June 13-16, Amsterdam, the Netherlands.